Table 4.
COVID follow‐up history, symptoms, and outcomes
| Characteristic | N = 40 a |
|---|---|
| Follow‐up COVID history | |
| Vaccinated | 15 (37.5%) |
| Pulmonary rehab referral | 5 (13.2%) |
| Follow‐up symptoms | |
| Months post‐COVID | 6.7 (4.9, 8.6) |
| Dyspnea | 6 (15.0%) |
| Cough | 5 (12.5%) |
| Chest pain | 8 (20.0%) |
| SOB during exercise | 27 (67.5%) |
| Follow‐up bronchodilator measures | |
| Normal spirometry | 26 (89.7%) |
| FVC prebronchodilator (%) | 100 (12) |
| FEV1 prebronchodilator (%) | 101 (92–106) |
| FEF 25%–75% prebronchodilator (%) | 90 (80–107) |
| Oxygen saturation (%) | 98.0 (97.0–98.5) |
| Follow‐up 6MW outcomes | |
| 6 MWD (m) | 594 (549–614) |
| HR pre‐6MW (bpm) | 84 (19) |
| HR post‐6MW (bpm) | 131 (25) |
| HR 6 MW change (bpm) | 47 (13) |
| Borg dyspnea post 6 MW | 3.0 (2.0–4.0) |
| Borg fatigue post 6MW | 3.0 (1.5–5.0) |
Abbreviations: 6MWD, 6‐min walk distance; FEF, forced expiratory flow; FEV, forced expiratory volume; FVC, forced vital capacity; HR, heart rate; IQR, interquartile range; SD, standard deviation.
a
n (%); mean (SD); median (IQR).